BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20180311T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20181104T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Bangkok
BEGIN:STANDARD
TZOFFSETFROM:+0700
TZOFFSETTO:+0700
TZNAME:+07
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20180311T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20181104T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20190310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20191103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20200308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20201101T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191115
DTEND;VALUE=DATE:20191116
DTSTAMP:20190711T053505Z
CREATED:20190711T053440Z
LAST-MODIFIED:20190711T053505Z
UID:29586-1573776000-1573862399@globalbiodefense.com
SUMMARY:Biological Safety for First Responders Course
DESCRIPTION:ABSA International and the Federal Bureau of Investigation will host a special Biological Safety for First Responders workshop on 15 November 2019 during the ABSA Annual Biosafety and Biosecurity Conference in Birmingham\, Alabama. \nThe course is being provided free of charge to the First Responder community by ABSA International. Participation is limited based on space availability. \nThe workshop is offered from 9am—11:30am or 1pm—3:30pm \nThe workshop will focus on biosafety basics\, research at universities\, regulatory aspects and current infectious disease issues as it relates to First Responders. \nWilliam So\, PhD\, FBI WMD Directorate Biological Countermeasures Unit\, will speak on challenges to responder safety in the current threat environment. \nDiscussions will include the differences between biological safety and infection control and how these differences can be used by First Responders to protect themselves and their family from potential exposures to infectious disease. \nThis course will be a great opportunity for the Birmingham area First Responders\, Public Health officials and the local biological safety community to network and begin partnerships in emergency response. \nFor registration please email firstresponder@absa.org
URL:https://globalbiodefense.com/event/biological-safety-for-first-responders-course/
LOCATION:Birmingham-Jefferson Convention Complex\, 2100 Richard Arrington Jr. Blvd N\, Birmingham\, AL\, 35203\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191112
DTEND;VALUE=DATE:20191114
DTSTAMP:20190928T155134Z
CREATED:20190928T155026Z
LAST-MODIFIED:20190928T155134Z
UID:30716-1573516800-1573689599@globalbiodefense.com
SUMMARY:General Membership Meeting of the Medical CBRN Defense Consortium and CWMD Consortium
DESCRIPTION:The Medical CBRN Defense Consortium and the Countering Weapons of Mass Destruction Consortium\, in conjunction with the JPEO-CBRND and DHS CWMD Office\, will host a consortia meeting and industry outreach event on 12-13 Nov 2019 in Bethesda\, Md. \nThis event will include multiple opportunities for Government\, industry\, and academia to interact and exchange information regarding upcoming business opportunities. \nThis event will focus on medical and non-medical CBRNE related requirements of the CBRN enterprise including the JPEO-CBRND\, DHS CWMD Office\, DTRA\, and others. \nAssistant Secretary McDonnell and other speakers will update participants on CWMD’s progress towards meeting its mission and expand on the Office’s current areas of emphasis. The event will include plenary sessions\, user panel\, and an expanded exhibit area. This event will include sessions with government\, industry\, academia\, and operational users who have an interest in countering chemical\, biological\, radiological\, and nuclear threats in the new CWMD mission space. \nMembership in MCDC is limited to US companies or US-based affiliates of foreign companies. Foreign companies cannot gain membership due to MCDC’s requirement that members obtain a DD2345 (military critical technical data agreement). However\, foreign companies can be subcontractors (team members) on projects awarded through the Other Transaction Agreement (OTA) as long as they can meet the terms and conditions of the OTA. The MCDC member awarded the project is responsible for flowing the applicable requirements down to the foreign company. \nThe Countering Weapons of Mass Destruction (CWMD) Consortium was formed in response to the Government’s expressed interest to establish an Other Transaction Agreement (OTA) with an eligible entity or group of entities\, to include industry\, academic\, and not-for-profit partners\, for advanced development efforts to support agencies that have a need to prototype new technologies related to Countering Weapons of Mass Destruction. The OTA Consortium is an enterprise partnership between the US Government (JPEO-CBRND) and the CWMD Consortium connected through a “contract-like” OTA.  This OTA operates outside the Federal Acquisition Regulations. \nFor more information and registration\, please contact the Medical CBRN Defense Consortium at MCDC@ati.org  or the CWMD Consortium cwmd@ati.org.
URL:https://globalbiodefense.com/event/general-membership-meeting-of-the-medical-cbrn-defense-consortium-and-cwmd-consortium/
LOCATION:Bethesda North Marriott Hotel & Convention Center\, 5701 Marinelli Rd\, Bethesda\, MD\, 20852\, United States
CATEGORIES:Conference,Industry Day
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191108
DTEND;VALUE=DATE:20191109
DTSTAMP:20240623T192726Z
CREATED:20191101T040408Z
LAST-MODIFIED:20240623T192726Z
UID:34125-1573171200-1573257599@globalbiodefense.com
SUMMARY:DHS CWMD Systems Support Directorate A&AS Pre-Solicitation Conference
DESCRIPTION:The Department of Homeland Security (DHS)\, Office of Procurement Operations (OPO)\, Countering Weapons of Mass Destruction (CWMD) intends to hold a Pre-Solicitation Conference for interested industry partners for the Systems Support Directorate (SSD)\, Operations Support Directorate (OSD)\, and Policy\, Plans\, and Analysis (PPA) Advisory and Assistance Services (A&AS) requirements on Friday\, November 8\, 2019. \nThe purpose of the Pre-Solicitation Conference is to discuss the SSD\, OSD\, and PPA requirements and address additional industry questions. \nWe have received many comments and questions regarding the limitation of future contracting and organizational conflict of interest clauses. In advance of posting our responses to industry comments and questions\, we can advise you that our intent is to revise those clauses in order to allow a vendor to compete as a prime and/or sub on all three A&AS awards (SSD\, OSD & PPA). \nThe government intends to post responses to industry comments received in response to the SSD\, OSD\, and PPA draft solicitations no later than 5:00 PM eastern time on Wednesday\, November 6\, 2019.
URL:https://globalbiodefense.com/event/dhs-cwmd-systems-support-directorate-aas-pre-solicitation-conference/
CATEGORIES:Conference,Industry Day
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191107
DTEND;VALUE=DATE:20191110
DTSTAMP:20190308T184650Z
CREATED:20181109T022807Z
LAST-MODIFIED:20190308T184650Z
UID:18471-1573084800-1573343999@globalbiodefense.com
SUMMARY:8th FIDSSA Congress - Federation of Infectious Diseases Societies of Southern Africa
DESCRIPTION:The 8th Federation of Infectious Diseases Societies of Southern Africa FIDSSA Congress 2019 will be held at the Indaba Hotel and Conference Centre\, Johannesburg\, South Africa from 7-9 November 2019. \nThis biennial FIDSSA Congress attracts local and international experts to lead conversations on a wide spectrum of cutting-edge infectious diseases topics relevant to the region and the African continent. Since its formation\, FIDSSA has contributed substantially to an integrated approach of tackling the major problems of infectious diseases in southern Africa. \nHighlighted session topics include: \n\nDeaths in newborn babies with healthcare-associated infections\nNew technology to detect neonatal unit outbreaks\nNew drug-resistant TB regimens for children and adults and new trials\nNew childhood vaccines\nHIV treatment interruptions for diagnostic purposes\nRapid diagnostics to transform the management of curable STIs in South Africa\nManagement of syphilis in an era of penicillin shortages\nIntegration of antimicrobial stewardship into sepsis pathways\nWhole genome sequencing and novel diagnostics to aid antimicrobial stewardship\nStewardship: Leveraging the “butterfly effect” of hand hygiene\nNew rabies vaccine guideline\nNew yellow fever guideline\nRoll out of PrEP in SA\nFlucytosine for cryptococcal meningitis\nAcinetobacter – the new MRSA?\nPhage therapy for biofilms in device-related infections\nRole of the environment in transmission of healthcare-associated infections\nNon-culture-based diagnostic testing for antimicrobial resistance\, mycology\n\nPre-congress workshops will be held on Thursday\, 7 November 2019 by the Infection Control Society of Southern Africa\, South African Society for Clinical Microbiology\, and South African Antimicrobial Stewardship Programme. \nAbstract submissions deadline: 24 June 2019\nOnline registration deadline: 13 October 2019 \nPlease visit the FIDSSA Congress 2019 website for more information.
URL:https://globalbiodefense.com/event/fidssa-federation-of-infectious-diseases-societies-of-southern-africa/
LOCATION:Indaba Hotel\, Spa and Conference Centre\, William Nicol Dr &\, Pieter Wenning Rd\, Fourways\, 2021\, South Africa
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2018/11/fidssa-congress-2019-infectious-diseases.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191105T163000
DTEND;TZID=America/New_York:20191105T183000
DTSTAMP:20240118T174426Z
CREATED:20191021T025113Z
LAST-MODIFIED:20240118T174426Z
UID:31068-1572971400-1572978600@globalbiodefense.com
SUMMARY:People\, Pigs\, Plants\, and Planetary Pandemic Possibilities
DESCRIPTION:Come learn about the One Health concept with experts in the public\, private\, and academic fields.\n\n\nThe George Mason University Next Gen Global Health Security Network and the GMU Biodefense Discussion Group are sponsoring a GMU One Health Day Panel Discussion on November 5\, 2019. \nThe event will take place from 4:30pm to 6:30pm in Van Metre Hall at the GMU Arlington Campus. Panel Members will include: \n\nMichael E. von Fricken MPH\, PhD\, GMU Global and Community (GCH) Health Security\nJarod Hanson DVM\, PhD\, Associate Editor at Program for Monitoring Emerging Diseases\nWilly A. Valdivia-Granda CEO\, Orion Integrated Biosciences\, INC.\nTaylor Winkleman DVM\, LMI\, Georgetown University\, Next Gen GHS Network\n\nThis panel will discuss the One Health approach through the various lens of their real world experiences. Discussions and interactions with the audience will address insightful views of innovation and emerging technology developments for biosafety and biosecurity. \nSpace will be capped at 35 participants\, so register as soon as possible to ensure your spot in the audience. The final day to register for the event is November 1st.
URL:https://globalbiodefense.com/event/people-pigs-plants-and-planetary-pandemic-possibilities/
LOCATION:George Mason University Schar School of Policy and Government\, Room 310\, Fairfax Drive\, Arlington\, VA\, 22201\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/12/livestock-risk-protection-swine-infections.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191103
DTEND;VALUE=DATE:20191107
DTSTAMP:20190928T193145Z
CREATED:20190928T193145Z
LAST-MODIFIED:20190928T193145Z
UID:30723-1572739200-1573084799@globalbiodefense.com
SUMMARY:APRC2 - Asia Pacific Rickettsia Conference 2019
DESCRIPTION:The 2nd Asia Pacific Rickettsia Conference\, APRC2 2019\, will be held 3-6 November 2019 in Chiang Rai\, Thailand. \nRickettsiae and rickettsial diseases are a major cause of illness in humans and animals throughout the Asia Pacific region. This conference is of interest to medical doctors\, veterinarians\, public health professionals\, epidemiologists\, diagnostic laboratory personnel\, entomologists and scientists. \nAgenda topics of interested include: \n\nBiosafety and biosecurity requirements for Orientia spp. diagnosis and research\nScrub typhus and the misconception of doxycycline resistance\nRickettsia rickettsii whole cell antigen vaccine confers protection against Rocky Mountain spotted fever\nDetection of Rickettsia species in Haemaphysalis flava from the Republic of Korea\nMolecular detection of Rickettsia spp. in dogs and Coxiella burnetii in ruminants in the Philippines\nEvidence of Q fever and rickettsial disease in Chile\nRisk factors for scrub typhus\, murine typhus and spotted fever sero-positivity in urban areas\nProspective\, open-label\, randomized trials of doxycycline versus azithromycin for the treatment of uncomplicated murine typhus and scrub typhus\nReview of diagnostic cut-offs for murine typhus IgM and IgG IFAs\nInBios Scrub Typhus Detect IgG and IgM ELISA kits for the diagnosis of scrub typhus acquired in Chile: proposed cut-off values\nThe biology of emerging Rickettsia felis rickettsiosis\nMetagenomic approach to characterizing disease epidemiology in a disease-endemic environment\n\nPlease visit APRC2 2019 website for more information.
URL:https://globalbiodefense.com/event/aprc2-asia-pacific-rickettsia-conference-2019/
LOCATION:The Riverie by Katathani Hotel\, 1129 Kraisorasit Rd\, Chiang Rai\, 57000\, Thailand
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191102
DTEND;VALUE=DATE:20191107
DTSTAMP:20190927T170437Z
CREATED:20190927T165804Z
LAST-MODIFIED:20190927T170437Z
UID:30689-1572652800-1573084799@globalbiodefense.com
SUMMARY:APHA 2019 Annual Meeting and Expo
DESCRIPTION:The American Public Health Association will host the APHA 2019 Annual Meeting and Expo on 2-6 Nov 2019 in Philadelphia\, Pennsylvania. \nJoin nearly 13\,000 public health colleagues at APHA 2019 for an extensive lineup of Continuing Education learning sessions and a Public Health Expo. \nSession topics of interest highlighted by the Global Biodefense staff include: \n\nNursing student willingness to respond to high-consequence infectious disease outbreaks\nCollaboration Across three nations for improved infectious disease surveillance\nInfectious disease agents of zoonotic potential of healthy horses in an exhibition setting\nComparing vector and human surveillance strategies to detect arbovirus transmission\nPublic health implications of veterinary telemedicine\nNeisseria meningitidis in Houston\, TX: 3-year data\nAssessing the Impact of ehealth ssage on seasonal influenza vaccine uptake in adults\nMajor challenges for successful hepatitis B vaccination in low resource settings\nEstimation of infectious disease dynamics: Application of a recurrent neural network\nIntersection of Race\, Gender and Vaccination Uptake during the 2009 H1N1 Influenza Pandemic\nAssessing the global prevalence of CYP2D6 haplotype variation\, and the implications for primaquine distribution and Plasmodium vivax control\nEnhancing the informatics response to the Zika epidemic in Puerto Rico: A case study to improve laboratory testing capacity and information management processes\nCross sectional study of employment status of recent physician graduates in the Democratic Republic of Congo\nMotivations and barriers associated with physician volunteerism for an International Telemedicine Organization\nA case report of acute flaccid paralysis associated with arboviruses infection in Panama\nEffect of land use\, land cover\, and climate change on the incidence and outbreak of Japanese Encephalitis disease among Asian population\nRole of gender and socioeconomic status as risk factors for emerging infectious disease transmission in Bangladesh\nDetection of infectious disease agents from the respiratory tract and conjunctiva of cats within animal shelters in the United States\nA comparison of common environmental and demographic associations across multiple tick-borne diseases in the United States\nAdaptation of the One Health Zoonotic Disease Prioritization Tool\n\nPlease visit the APHA 2019 website for more information. \n 
URL:https://globalbiodefense.com/event/apha-2019-annual-meeting-and-expo/
LOCATION:Pennsylvania Convention Center\, 1101 Arch St.\, Philadelphia\, PA\, 19107\, United States
CATEGORIES:Conference,Continuing Education
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191028
DTEND;VALUE=DATE:20191029
DTSTAMP:20191020T223743Z
CREATED:20191020T223743Z
LAST-MODIFIED:20191020T223743Z
UID:31050-1572220800-1572307199@globalbiodefense.com
SUMMARY:DARPA Proposers Day: Nucleic Acids On-Demand Worldwide (NOW)
DESCRIPTION:The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) will host a Proposers’ Day on October 28\, 2019 in Arlington\, Virginia. \nThe event will gather the planned proposer community in support of the Nucleic Acids On-Demand Worldwide (NOW) program\, which aims to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to rapidly produce\, formulate\, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA). \nThe Proposers Day will include brief overview presentations by government personnel\, an\ninformation session to respond to questions from participants\, “lightning” talks (three minutes\,\none PowerPoint slide)\, posters for potential proposers to highlight technical capabilities or to\npromote teaming\, and private sidebar meetings between the DARPA government team and\npotential proposer teams. \nParticipant presentations and sidebar meetings must be scheduled via the registration website. Lightning talk presentations will be made accessible to the proposer community on the NOW program website after presentation at the Proposers day. It is expected that NOW will require strong teaming efforts to successfully innovate and integrate critical technologies necessary to meet the metrics of the NOW program. \nAttendance at this event is not a requirement for submission of a proposal or selection for\nfunding. Information relayed during the Proposers Day will be made available on the BTO\nsection of the DARPA Opportunities page. \nAttendance is open to individuals who are U.S. Citizens\, U.S. Permanent Residents\, and Foreign Nationals. Upon entry to the physical meeting\, all attendees will be required to present valid\, Government-issued photo identification. \nREGISTER HERE. Registration for physical participation will close on October 23\, 2019 at 12:00 PM ET (updated from original date of October 21\, 2019 at 12:00 PM ET) or when capacity is reached and webinar participation will close on October 25\, 2019 at 12:00 PM ET or when webinar capacity is reached\, whichever comes first.Registration is limited by the venue capacity\, and early registration is strongly recommended. There will be no on-site registration. \nGlobal Biodefense is a publisher providing visibility on this important development program. For all attendance or logistics information\, please contact the event sponsor.
URL:https://globalbiodefense.com/event/darpa-proposers-day-nucleic-acids-on-demand-worldwide-now/
LOCATION:Executive Conference Center (ECC)\, 4075 Wilson Boulevard\, Arlington\, VA\, 22203\, United States
CATEGORIES:Industry Day,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191025T100000
DTEND;TZID=America/New_York:20191025T123000
DTSTAMP:20191020T221335Z
CREATED:20191020T221258Z
LAST-MODIFIED:20191020T221335Z
UID:31046-1571997600-1572006600@globalbiodefense.com
SUMMARY:October Bagels and Bio/Chem Defense
DESCRIPTION:Another session of Bagels and Bio/Chem Defense will be held on Friday\, October 25th at the National Academies Keck Center (500 Fifth Street NW\, Washington DC). \nThis month will be an expanded session (from 10:00 a.m. to 12:30 p.m.) focused on qualitative frameworks that could provide the basis for structured expert discussions of the potential security concerns posed by emerging technologies in the life sciences. \nIn August the National Academies and the InterAcademy Partnership organized a one-day workshop during the BWC Meeting of Experts to give a small international group of people attending the sessions the opportunity to pilot test how two such frameworks might be applied to BWC-relevant case examples. This month’s session will feature a scaled-down version of the exercise. \nParticipants will have the opportunity to work in small groups to apply either the framework from the 2018 National Academies report\, Biodefense in the Age of Synthetic Biology or the technology assessment portion of the framework from Jonathan Tucker’s 2012 project on Innovation\, Dual Use\, and Security. \nThis event is part of the National Academies of Sciences\, Engineering\, and Medicine’s discussion series on biological and chemical defense and security issues. It is free and open to the public\, but you must register in advance. Bagels and beverages will be provided to attendees.
URL:https://globalbiodefense.com/event/october-bagels-and-bio-chem-defense/
CATEGORIES:Conference,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191023T083000
DTEND;TZID=America/New_York:20191023T123000
DTSTAMP:20191022T201546Z
CREATED:20191010T200908Z
LAST-MODIFIED:20191022T201546Z
UID:31093-1571819400-1571833800@globalbiodefense.com
SUMMARY:FBI Biosecurity Workshop
DESCRIPTION:The FBI WMD Directorate will host a 4-Hour Biosecurity Workshop on 23 Oct 2019 at Skidmore College in Saratoga Springs\, NY. \nThe event is designed to improve cooperation among law enforcement agencies and research institutions to mitigate potential biosecurity issues that may affect public health and safety. \nThe objectives are to: \n1) Identify biosecurity roles and responsibilities of law enforcement agencies\n2) Identify biosecurity roles and responsibilities of research institutions\n3) Identify benefits and potential obstacles to improve cooperation among law enforcement agencies and research institutions regarding biosecurity\n4) Identify methods of improving communications among biosecurity stakeholders \nBiosecurity includes a range of topics that require the collaboration and coordination of a diverse set of stakeholders. The range of topics discussed in this workshop includes international and domestic terrorism\, cyber security\, protection of intellectual property/proprietary information\, dual-use research\, workplace violence\, security challenges with the rapid advances in research and technology innovations\, and insider-threat mitigation. \nRelationships between the scientific and security communities must be built on trust and understanding in order to develop effective\, sensible mitigation strategies\, communication pathways\, and policies to meet these challenges. \nThe audience for this course includes VP of Research (Institution Official)\, Responsible Officials\, Biosafety Officials\, Environmental health and safety officials\, Primary Investigators/research directors\, Laboratory Supervisors/ managers\, Campus Police Department\, State and Local Police Departments\, Emergency Fire responders (to include HazMat)\, State/Local public health\, Office of Emergency Management\, Institution Human Resources Department\, Institution Cyber/IT Department\, Institution Office of General Counsel (Legal Department)\, and Public Information Officials. \nYou must be a US citizen or have prior approval to take this course. The FBI reserves the right to determine eligibility for this course. The scope\, concept\, and content of this course were developed by the FBI. \nTo register for this Workshop\, please contact FBI Operational Support Specialist (OST) Vincent Soldani directly at vsoldaniiii@fbi.gov \nPoint of Contact regarding this training is Weapons of Mass Destruction Coordinator\, Thomas Stewart: \nThomas Stewart\nWMD Coordinator\nFBI\, Albany Division\n200 McCarty Ave\nAlbany\, NY 12209\ntstewart2@fbi.gov\n(518) 281-2239
URL:https://globalbiodefense.com/event/fbi-biosecurity-workshop/
LOCATION:Skidmore College\, Saratoga Springs\, NY\, 12866\, United States
CATEGORIES:Conference,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191022
DTEND;VALUE=DATE:20191023
DTSTAMP:20190907T222955Z
CREATED:20190907T222920Z
LAST-MODIFIED:20190907T222955Z
UID:30280-1571702400-1571788799@globalbiodefense.com
SUMMARY:ASM Agar Art Contest Submission Deadline
DESCRIPTION:ASM’s 5th Agar Art Contest celebrates the beautiful and diverse world of microbes. Submit your bioart masterpiece no later than October 22\, 2019. \n \nThere are different competition categories for professionals\, amateur enthusiasts and for kids (with adult supervision). Pieces must be created safely in the appropriate Bio Safety Level environment for the organisms used. For more information\, please consult ASM’s Guidelines for Biosafety in Teaching Laboratories. \nLearn more
URL:https://globalbiodefense.com/event/asm-agar-art-contest/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191016T123000
DTEND;TZID=America/New_York:20191016T140000
DTSTAMP:20190928T151358Z
CREATED:20190928T151347Z
LAST-MODIFIED:20190928T151358Z
UID:30710-1571229000-1571234400@globalbiodefense.com
SUMMARY:Congressional Briefing: Preventing Outbreaks: Working Together to Increase Vaccine Confidence
DESCRIPTION:A congressional briefing co-sponsored by The American Academy of Pediatrics\, Adult Vaccine Access Coalition\, BIO\, NACCHO\, Trust for America’s Health\, and Vaccinate Your Family will take place on 16 Oct 2019 at 12:30 p.m. \nScheduled Speakers: \n\nJ. Nadine Gracia\, MD\, Executive Vice President and COO\, Trust for America’s Health\nJeffrey Duchin\, MD\, Health Office\, Public Health-Seattle and King County\nRiki Graves\, MHA\, The Immunization PartnershipAmy Pisani\, MS\, Executive Director\, Vaccinate Your Family\nDr. Nancy Messonnier\, MD\, Director\, National Center for Immunization and Respiratory Disease\, Centers for Disease Control and Prevention \nWith remarks by The Honorable Michael C. Burgess\, M.D. (R-TX) and the Honorable Kim Schrier (D-WA).\n\nRSVP to participate here.
URL:https://globalbiodefense.com/event/congressional-briefing-preventing-outbreaks-working-together-to-increase-vaccine-confidence/
LOCATION:Rayburn House Office Building\, Washington\, DC\, United States
CATEGORIES:Conference,Policy-Legislative
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191015
DTEND;VALUE=DATE:20191017
DTSTAMP:20190914T001844Z
CREATED:20190722T154929Z
LAST-MODIFIED:20190914T001844Z
UID:29649-1571097600-1571270399@globalbiodefense.com
SUMMARY:BARDA Industry Day 2019
DESCRIPTION:The Biomedical Advanced Research and Development Authority (BARDA) annual Industry Day 2019 conference on U.S. government medical countermeasures is planned for 15-16 October 2019 in Washington\, D.C. \nA component of the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR)\, BARDA will brief on program priorities and network with public and private sector colleagues on developing medical countermeasure or platform technology to combat chemical\, biological\, radiological\, or nuclear (CBRN) threats\, pandemic influenza or other emerging infectious diseases. \nThe Industry Day event will be held at Grand Hyatt and Washington Marriott at Metro Center in Washington\, DC. \nBARDA Industry Day brings together over >1\,000 participants to exchange information about the government’s public health needs\, and industry’s technologies\, capabilities\, and products that can fill those requirements. \nLightning Talks to showcase innovative discoveries and promote networking growth at the conference will be featured on the morning of October 16th. \nLightning Talks are intentionally designed to be brief\, energetic\, and full of information to pique the curiosity of industry and government colleagues and prospective partners. If you are interested in submitting a topic to present on behalf of yourself or your company\, please enter your information as requested and provide a brief (maximum 500 word) summary of your proposed presentation\, with optional 1 slide. \nLightning Talk applications must be received by 11:59 PM ET September 13\, 2019. BARDA will notify those that have been accepted for Lightning Talks the week of September 22\, 2019. Learn more here. \nPlease visit MedicalCountermeasures.gov or http://bit.ly/BARDA2019 for official updates in the BID 2019 event.
URL:https://globalbiodefense.com/event/barda-industry-day-2019/
LOCATION:Washington DC Area\, Washington\, DC\, United States
CATEGORIES:Conference,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/07/barda-industry-day-aspr-register.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191015
DTEND;VALUE=DATE:20191016
DTSTAMP:20191011T180518Z
CREATED:20191011T180518Z
LAST-MODIFIED:20191011T180518Z
UID:30990-1571097600-1571183999@globalbiodefense.com
SUMMARY:National Latinx AIDS Awareness Day
DESCRIPTION:National Latinx AIDS Awareness Day\, October 15\, is observed each year to focus on the continuing and disproportionate impact of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) on Hispanics/Latinos in the United States. \nThe Latino Commission on AIDS (LCOA)\, the Hispanic Federation  and other organizations organize this day to build capacity for non-profit organizations and health departments to reach Latino/Hispanic communities\, promote HIV testing\, and provide HIV prevention information and access to care. \nIn 2017\, 26% of newly diagnosed HIV infections occurred in Hispanics/Latinos. Seventy-five percent of these newly diagnosed HIV infections in Hispanics/Latinos were in men who have sex with men (MSM)\, and an additional 3% were in MSM who inject drugs[1]. \nAn analysis of the behaviors of Hispanic/Latino MSM included in CDC’s National HIV Behavioral Surveillance system found that nearly 75% reported having had condomless anal sex during 2017 [2]. However\, because some of these MSM reported using preexposure prophylaxis (PrEP)\, fewer than 60% of those who were non–U.S.-born and fewer than 50% of those who were U.S.-born were having unprotected anal sex[2]. \nNational Latinx AIDS Awareness Day is an opportunity to encourage increased HIV prevention efforts among Hispanics/Latinos. CDC supports testing\, linkage to and engagement in care and treatment\, and other efforts to reduce the risk for acquiring or transmitting HIV infection. \nMore information is available at HIV and Hispanics/Latinos and HIV and Hispanic/Latino Gay and Bisexual Men. \nReferences\n\nCDC. Diagnoses of HIV infection in the United States and dependent areas\, 2017. HIV surveillance report\, vol. 29. Atlanta\, GA: US Department of Health and Human Services\, CDC; 2018. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hivsurveillance-report-2017-vol-29.pdfpdf icon\nTrujillo L\, Chapin-Bardales J\, German EJ\, Kanny D\, Wejnert C; National HIV Behavioral Surveillance Study Group. Trends in sexual risk behaviors among Hispanic/Latino men who have sex with men—19 urban areas\, 2011–2017. MMWR Morb Mortal Wkly Rep 2019;68:873–9.
URL:https://globalbiodefense.com/event/national-latinx-aids-awareness-day/
LOCATION:United States\, United States
CATEGORIES:Awareness Event
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/10/awareness-banner-latinx-aids.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191002
DTEND;VALUE=DATE:20191007
DTSTAMP:20190812T143115Z
CREATED:20190812T142839Z
LAST-MODIFIED:20190812T143115Z
UID:29965-1569974400-1570406399@globalbiodefense.com
SUMMARY:IDWeek 2019
DESCRIPTION:IDWeek 2019\, the combined annual meeting of IDSA\, SHEA\, HIVMA\, and PIDS\, will be held 2-6 October 2019 in Washington\, DC. \nIDWeek is geared toward healthcare professionals in infectious diseases and healthcare epidemiology and prevention\, including researchers\, clinicians\, quality and patient safety practitioners\, epidemiologists\, and public health officials. \nAgenda topics of interest highlighted by the Global Biodefense staff include: \n\nOutbreak Response in the Genomic and Information Age\nHow Genomics is Revolutionizing Biomedicine Across Disciplines\, Across Continents\nUS Measles Outbreak: Summary of US Epi Data in General and Specific NYC Outbreak\nChallenging Cases in Pediatric Infectious Diseases\nThe Next Generation of ID Host Response Biomarkers\nFDA Perspective on Metagenomic Sequencing in Infectious Diseases\nProcalcitonin and Common Febrile Illnesses: Hype or Help?\nWhat’s New in the Field of Clinical and Epidemiological Sciences\nLatent TB in the US\nDisplaced: Infectious Disease Impacts on Refugee and Migrant Populations\nThe Ideal Infection Prevention Hospital: Air Handling\nUpdates on Interferon-Gamma Release Assay Performance\nCyclospora: Epidemiology\, Diagnosis and Treatment\nAuthophagy and Autophagy-Related Pathways in Host Defense\nInnate Lymphocytes and Trained Immunity\nInfluenza Vaccines: Are We Ready for Different Vaccines for Different Populations?\nThe Rationale for Using Phages as Therapeutic Weapons\nPhage Lysins Effectively Target MDR ESKAPE Pathogens\nTargeting Contact Precautions: It’s About the Pathogen\nRapid Diagnostics and Resistance: Accelerate\, BacterioScan\, Klaris\, LifeScale\, Roche\, Selux\, Specific Diagnostics\nAntenatal Zika Virus Exposure\nAcute Flaccid Myelitis – National Perspective\n\nPlease visit the IDWeek 2019 website to register.
URL:https://globalbiodefense.com/event/idweek-2019/
LOCATION:Walter E. Washington Convention Center\,  801 Mt Vernon Pl NW\, Washington\, DC\, 20001\, United States
CATEGORIES:Conference,Continuing Education
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20190924T080000
DTEND;TZID=America/Denver:20190925T170000
DTSTAMP:20190906T132235Z
CREATED:20190906T132235Z
LAST-MODIFIED:20190906T132235Z
UID:30250-1569312000-1569430800@globalbiodefense.com
SUMMARY:Medical Countermeasures Point of Distribution (POD)
DESCRIPTION:The National Center of Excellence At Texas A&M (TEEX) will be delivering their two day course on Point of Distribution (POD) Medical Countermeasures on Sept 24 and 25. \nThis a rare training opportunity as the course is being taught in Western Montana and being offered at no cost! \nClass size is limited\, register quickly!
URL:https://globalbiodefense.com/event/medical-countermeasures-point-of-distribution-pod/
LOCATION:Salish Kootenai College\, 58138 U.S. 93\, Pablo\, MT\, 59855\, United States
CATEGORIES:Conference,Training
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/09/df7e419f5f73e5fb3e28da32e23bd8c1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190915
DTEND;VALUE=DATE:20190919
DTSTAMP:20190812T154325Z
CREATED:20190812T154236Z
LAST-MODIFIED:20190812T154325Z
UID:29971-1568505600-1568851199@globalbiodefense.com
SUMMARY:13th Vaccine Congress
DESCRIPTION:Organizers from Elsevier’s journal Vaccine will host the 13th Vaccine Congress 15-18 September 2019 in Bangkok\, Thailand. \nThe congress will bring together leading experts from all over the world to share the latest cutting-edge discoveries in the field. \nAgenda topics of interest highlighted by the Global Biodefense staff include: \n\nInsertion-responsive microneedles for rapid intradermal delivery of influenza vaccine\nImmunogenicity of virus-like particle (VLP)-based coronavirus vaccines\nA brief review of adversomics: understanding genetic drivers for adverse events after vaccination\nDeveloping a novel\, safe and effective platform for generating flavivirus vaccines\nNovel adenoviral vector platform for developing a universal influenza vaccine\nChicken IFITM knockout technology for increased vaccine production\nThe role of the microbiome in host interactions and vaccine responses\nOptimized recombinant Newcastle disease virus expressing the F protein of respiratory syncytial virus has improved antigen expression levels and immunogenicity\nIdentification of immunostimulatory domains of flagellin for better adjuvant design\nReprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology\nDevelopment of bat stem cell lines by somatic reprogramming to study bat-derived\nhighly pathogenic viruses\nVaccination with 1/6th standard dose of a split inactivated influenza vaccine using the Nanopatch™\ninduces comparable immune responses to conventional full-dose intramuscular injection\nMucosal immunity in therapeutic and prophylactic vaccine trials\nTranslating the intestinal microbiome for oral vaccine performance\nNeuraminidase-based influenza virus vaccines\nAssessment of outer membrane vesicles derived from Escherichia coli Nissle 1917as a novel mucosal adjuvant in intranasal inactivated influenza vaccine\nEnhancing Chikungunya Virus Immunity By Improved Vaccination\nPre-clinical protective efficacy of a VLP-based vaccine against Zika virus\nNeedle Adapters and Needle-free Injectors for Intradermal Administration of Fractional Dose of\nInactivated Poliovirus Vaccine\n\nPlease visit the 13th Vaccine Congress website for more information and to register for the event.
URL:https://globalbiodefense.com/event/13th-vaccine-congress/
LOCATION:Avani Riverside Hotel\, 257 Charoennakorn Road\, Thonburi\, Bangkok\, 10600\, Thailand
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190913
DTEND;VALUE=DATE:20190914
DTSTAMP:20190904T174022Z
CREATED:20190821T041439Z
LAST-MODIFIED:20190904T174022Z
UID:30062-1568332800-1568419199@globalbiodefense.com
SUMMARY:Lightning Talks Application Deadline - BARDA Industry Day Presentations
DESCRIPTION:Submit your application to participate in the BARDA Industry Day 2019 Lightning Talks on 16 Oct 2019. \nLightning Talks are intentionally designed to be brief\, energetic\, and full of information to pique the curiosity of industry and government colleagues and prospective partners. If you are interested in submitting a topic to present on behalf of yourself or your company\, please enter your information as requested and provide a brief (maximum 500 word) summary of your proposed presentation\, with optional 1 slide. \nApplications will be evaluated on the following criteria: \n\nRelevance to ASPR\, BARDA \, and DRIVe mission\nRelevance to BARDA Industry Day 2019 theme\, “Catalyzing Health Security”\nGoals of proposed talk: Are you seeking partnerships/collaborations? Accelerating product development? Looking for new applications for existing technologies?\n\nApplications must be received by 11:59 PM ET Friday\, September 13\, 2019. BARDA will notify those that have been accepted for Lightning Talks the week of September 22\, 2019. \nSubmit Your Application to Present Here: Lightning Talks Submission Form
URL:https://globalbiodefense.com/event/lightning-talk-application-deadline-barda-industry-day-presentations/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190911T090000
DTEND;TZID=America/New_York:20190911T170000
DTSTAMP:20190906T150226Z
CREATED:20190906T144340Z
LAST-MODIFIED:20190906T150226Z
UID:30253-1568192400-1568221200@globalbiodefense.com
SUMMARY:National Biodefense Science Board: Public Meeting
DESCRIPTION:The HHS Office of the Secretary is hosting the National Biodefense Science Board (NBSB) Public Meeting in Washington\, DC\, on September 11\, 2019. The meeting is also available for remote participation by teleconference. \nThe purpose of the meeting is to gather information to develop expert advice provided by NBSB and guidance to the Secretary on scientific\, technical\, and other matters of special interest to HHS regarding current and future chemical\, biological\, nuclear\, and radiological (CBRN) agents\, whether naturally occurring\, accidental\, or deliberate. \nAgenda items include: \n\nPresentation from the Disaster Medicine Working Group (DMWG)\nExploring Issues in Biodefense Science: Development and Use of Animal Models to Enhance Rapid Approval of Novel MCM\nASPR Program Update: Vision for the Pediatric Disaster Care Centers of Excellence Cooperative Agreement\n\nTeleconference Information:\nToll Numbers (International Callers): 773-799-3992\nToll Free Number: 888-417-0384\nParticipant passcode: 3609874 (Listen only; Public callers\, use for the public NBSB phe.gov site) \nFor further information contact: CAPT Christopher Perdue\, MD\, MPH\, Designated Federal Official\, NBSB\, ASPR\, HHS; 202-401-5837; christopher.perdue@hhs.gov
URL:https://globalbiodefense.com/event/national-biodefense-science-board-public-meeting/
LOCATION:O’Neil Building\, 200 C Street SW\, Washington\, DC\, 20515
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/09/national-biodefense-science-board.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20190911T000000
DTEND;TZID=America/Los_Angeles:20190913T235959
DTSTAMP:20190803T220610Z
CREATED:20190621T165248Z
LAST-MODIFIED:20190803T220610Z
UID:29339-1568160000-1568419199@globalbiodefense.com
SUMMARY:Legionella Conference 2019
DESCRIPTION:The Legionella Conference 2019\, hosted by NSF International and the National Environmental Health Association\, will be held 11-13 September 2019 in Los Angeles\, California. \n\n\n\nAn international lineup of public health and sustainability experts from four continents will discuss complex hospital water systems\, cooling towers\, proactive water quality monitoring and other topics at the conference. \n\n\n\nThe 2019 Legionella Conference theme\, “Building Water Systems: The Sustainability and Public Health Nexus\,” centers on how both industries can help align water and energy sustainability and public health goals. \n\n\n\nAgenda topics of interest highlighted by the Global Biodefense staff include: \n\n\n\nHow Public Health Officials Can Make Defensible Decisions With Limited Data During an OutbreakBuilding the Capacity to Lead Investigations: Finding the Best ResponseWater Conservation Goals and Public Health – Responding to Unintended ConsequencesA Novel Water Heating System for Pathogen ControlWhole-Genome Sequencing and Comparative Genome Analysis: A Pangenome Approach to Understand Population Diversity\, Antimicrobial Resistance\, and Adaptive Mechanisms of Bacterial Pathogens Within the Water System of Large Occupational BuildingsPlace of Point of Use Filters in a Multifaceted Strategy Against Waterborne HAIS in Hospital SettingsNew Open-Cell Foam Sampling Methods for Legionella to Mitigate Risks of False Non-DetectsThe Basis for Criminal and Civil Liability for Public Health Officials in State Public Health Law and Ethical Perspective on Risk Communication During OutbreaksSummary of Performance of Legiolert™ Vs. Standard Methods for the Quantification of Legionella pneumophila in Non-Potable Water SamplesImproved Management of Legionella Risks Using Rapid On-Site Testing\n\n\n\nLearn more and register at the Legionella Conference 2019 website.
URL:https://globalbiodefense.com/event/legionella-conference-2019/
LOCATION:Westin Bonaventure Hotel and Suites\, 404 S Figueroa St\, Los Angeles\, California\, 90071\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190911
DTEND;VALUE=DATE:20190913
DTSTAMP:20190817T225348Z
CREATED:20190817T224214Z
LAST-MODIFIED:20190817T225348Z
UID:30036-1568160000-1568332799@globalbiodefense.com
SUMMARY:2019 FDA Science Forum
DESCRIPTION:The 2019 FDA Science Forum will be held on 11-12 September 2019 in Silver Spring\, Md. The event may be attended in-person or via Webcast (pre-registration is required). \nFDA’s Science Forum welcomes the public\, industry\, academia\, patient advocates\, sister agencies\, and current and potential collaborator to learn how FDA’s researchers are using novel science and technologies to inform FDA’s regulatory decision-making—and drive innovation. \nAgenda items of interest highlighted by the Global Biodefense staff include: \n\nEmerging & Pandemic Threat Preparedness\nBio-Terrorism Regulations and Food Security\nFDA Food Defense Efforts – A Preventive Approach to Food Terrorism\nCBER-Regulated Products: Preventing and Mitigating Shortages\nViolent Non-State Actor Use of Food as a Delivery System: Comparing ideological and Non-Ideological Perpetrators\nProduct Availability: A Drug Shortage Perspective\nMetagenomeTrakr Pilot Program for Rapid Foodborne Pathogen Detection\nAvian Influenza A Susceptibilities to Pulmonary Surfactant Protein D: Confirmation of N-glycan sub-type as a Pathogenic Factor in Influenza\nImmune Responses to Zika Infections\nInnovation in Science: Protecting People from Emerging Infectious Disease Threats\nFoodborne Outbreak Investigations in the Whole Genome Sequencing Era\nTracking antibiotic resistance in Salmonella: The role of the National Antimicrobial Resistance Monitoring System\nDeep Learning for Polypharmacy and Drug Repurposing\nC. elegans for Rapid Developmental Neurotoxicity Assessment of Mixtures\nCardiac and Hepatic Cellular Systems to Model Human Drug Effects\nThe VICTRE Project: The First All-In-Silico Imaging Clinical Trial\nDigital Biomarkers Discovery from Patient-Generated Health Data\nAI at FDA: Potential Utility and Regulatory Challenges\nAdvancing Digital Health and Artificial Intelligence\nImpacting Public Health Through Electronic Media: Empowering Consumers\, Patients\, and Other Stakeholders\nMetagenomeTrakr Pilot Program for Rapid Foodborne Pathogen Detection\nPreclinical pharmacology of novel synthetic opioids appearing in clandestine drug markets\nAssessing the structural and pharmacological similarity of newly identified drugs of abuse to controlled substances using PHASE\nAccelerating Innovation in Manufacturing Technology for Biomanufactured Products: Manufacturing U.S. and NIST\nOn the ‘Cyber-Securability’ of Medical Devices\n\nPlease visit the FDA Science Forum website to view the full agenda and register.
URL:https://globalbiodefense.com/event/2019-fda-science-forum/
LOCATION:FDA White Oak Campus\, 10903 New Hampshire Ave\, Silver Spring\, MD\, 20993\, United States
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/08/2019-fda-science-forum.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20190909T000000
DTEND;TZID=America/Los_Angeles:20190910T235959
DTSTAMP:20190803T172114Z
CREATED:20181223T184820Z
LAST-MODIFIED:20190803T172114Z
UID:18738-1567987200-1568159999@globalbiodefense.com
SUMMARY:Diagnostic Microbiology and Infectious Diseases Summit
DESCRIPTION:The Diagnostic Microbiology and Infectious Diseases Summit will be held 9-10 September 2019 in Dubai\, UAE. \n\n\n\nThis event provides a pivotal platform to explore outstanding strategies in Diagnostic Microbiology and Infectious Diseases. \n\n\n\nHighlighted topic sessions include: \n\n\n\nResistance and mechanisms of action of antifungalsImmunology of infectious diseasesClinical microbiologyEpidemiology of infectious diseases and public health concernsMedical and clinical case reportsDiagnostic and laboratory methodsInfection control and prevention\n\n\n\nFor additional details and registration\, please visit the Diagnostic Microbiology and Infectious Diseases Summit website.
URL:https://globalbiodefense.com/event/diagnostic-microbiology-and-infectious-diseases-summit/
LOCATION:Dubai\, UAE\, Dubai\, UAE
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/11/a69947efc015b3366f376f6b134bcc28.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190909
DTEND;VALUE=DATE:20190910
DTSTAMP:20190812T140040Z
CREATED:20190812T140040Z
LAST-MODIFIED:20190812T140040Z
UID:29961-1567987200-1568073599@globalbiodefense.com
SUMMARY:Comments Due:  2019 Draft Guidelines for the Prevention\, Diagnosis\, and Treatment of Lyme Disease
DESCRIPTION:The Infectious Diseases Society of America (IDSA)\, American Academy of Neurology (AAN)\, and American College of Rheumatology (ACR) are now accepting comments on the “2019 Draft Guidelines for the Prevention\, Diagnosis and Treatment of Lyme Disease.” Feedback is sought not only from physicians and healthcare professionals\, but also individuals affected by Lyme disease\, such as patients\, care givers\, patient organization members\, advocates\, and researchers. The deadline for submitting comments has been extended until Sept. 9\, 2019. \nTo view the draft guidelines\, supplementary materials\, and submit comments\, please see below. \n2019 Draft Guidelines for the Prevention\, Diagnosis and Treatment of Lyme Disease \n2019 Draft Supplement Materials for the Prevention\, Diagnosis and Treatment of Lyme Disease \nPublic comments are due by 5PM Eastern on 9 September 2019.
URL:https://globalbiodefense.com/event/comments-due-2019-draft-guidelines-for-the-prevention-diagnosis-and-treatment-of-lyme-disease/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190826T080000
DTEND;TZID=America/New_York:20190826T163000
DTSTAMP:20190822T155636Z
CREATED:20190822T155515Z
LAST-MODIFIED:20190822T155636Z
UID:30093-1566806400-1566837000@globalbiodefense.com
SUMMARY:Threat Reduction Advisory Committee (TRAC) Meeting
DESCRIPTION:The Federal Advisory Committee meeting of the Threat Reduction Advisory Committee (TRAC) will meet Monday\, August 26 at the Pentagon to conduct SECRET and higher-level discussions and deliberations on the continued viability of the Chemical Weapons Convention and Biological Weapons Convention\, in as far as current international agreements on chemical and biological weapons and the implementation and enforcement of those treaties. \nRead more: Pentagon Threat Advisory Committee to Meet
URL:https://globalbiodefense.com/event/threat-reduction-advisory-committee-trac-classified-meeting/
LOCATION:The Pentagon\, Washington\, DC\, 20301–1400\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190724T130000
DTEND;TZID=America/New_York:20190724T141500
DTSTAMP:20190621T172628Z
CREATED:20190621T172318Z
LAST-MODIFIED:20190621T172628Z
UID:29336-1563973200-1563977700@globalbiodefense.com
SUMMARY:Social Media Monitoring in Public Health Emergencies Webinar
DESCRIPTION:The National Association of County and City Health Officials (NACCHO) will “Social Media Monitoring in Public Health Emergencies” webinar on 24 July 2019 as part of a webinar series to help local health departments build capacity to engage in public health communication. \nHosted by and presented by the New York City Department of Health and Mental Hygiene\, “Social Media Monitoring in Public Health Emergencies“ will help participants learn how to use social media to monitor and respond to the spread of (mis)information during public health emergencies. Presenters will: \n\ndescribe the importance of being aware of public sentiment during a public health emergency;\nidentify how to use social media bidirectionally to both provide updates and collect public feedback; and\nshare scalable approaches for managing social media monitoring regardless of organizational budget.\n\nThe webinar will be recorded for on-demand viewing. REGISTER TO JOIN.\nTo view and register for the remainder of the webinars\, click here. If you have questions about this webinar series or are interested in joining NACCHO’s Public Health Communications Collaborative—a community of practice for public information officers and the like—please email Kim Rodgers.
URL:https://globalbiodefense.com/event/social-media-monitoring-in-public-health-emergencies-webinar-series/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190719
DTEND;VALUE=DATE:20190720
DTSTAMP:20240623T230911Z
CREATED:20190705T172317Z
LAST-MODIFIED:20240623T230911Z
UID:29483-1563494400-1563580799@globalbiodefense.com
SUMMARY:NASEM Workshop: Enhancing Private Sector Preparedness for 21st Century Health Threats
DESCRIPTION:The public is invited to participate in an upcoming workshop on Enhancing Private Sector Preparedness for 21st Century Health Threats on 19 July 2019. \nHosted by the National Academies of Sciences\, Engineering\, and Medicine (NASEM) Board on Health Sciences Policy\, the workshop aims to bring together public- and private-sector partners to discuss approaches to aligning health system incentives with the American public’s need for a healthcare system that is optimally prepared for day-to-day duties and responses to public health emergencies. \nTopics to be addressed include challenges around and opportunities for public–private collaboration\, levers to motivate private sector investment in preparedness\, and information/data elements that will improve situational awareness of system capabilities. \nRegistration for the event is required.
URL:https://globalbiodefense.com/event/nasem-workshop-enhancing-private-sector-preparedness-for-21st-century-health-threats/
CATEGORIES:Conference
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190719
DTEND;VALUE=DATE:20190720
DTSTAMP:20190421T174235Z
CREATED:20190421T172854Z
LAST-MODIFIED:20190421T174235Z
UID:26391-1563494400-1563580799@globalbiodefense.com
SUMMARY:Proposals Due: RNCP-Wide Dosimetry Guidance and Monitoring of Sources and Irradiation Protocols
DESCRIPTION:NIAID is soliciting proposals to assess the current state of radiation dosimetry within the Radiation Nuclear Countermeasures Program to develop a consistent means of comparison and reproducibility across institutes. \nConsider submitting an offer if you can provide services\, facilities\, expertise\, and capabilities needed to develop a centralized dosimetry harmonization effort. Ideally\, you will have preliminary data demonstrating consistent and accurate dosimetry exposures within a clearly defined radiation exposure system that is used for nonclinical radiation animal (and in vitro) studies in more than one animal species (e.g.\, mouse and nonhuman primate). \nRead the full article on this opportunity here.  \nResponses are due July 19\, 2019\, at 3 p.m. Eastern time.
URL:https://globalbiodefense.com/event/proposals-due-rncp-wide-dosimetry-guidance-and-monitoring-of-sources-and-irradiation-protocols/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190718T143000
DTEND;TZID=America/New_York:20190718T154500
DTSTAMP:20190621T172956Z
CREATED:20190521T172808Z
LAST-MODIFIED:20190621T172956Z
UID:29335-1563460200-1563464700@globalbiodefense.com
SUMMARY:Managing Media Relations During a Public Health Emergency
DESCRIPTION:For the second year in a row\, NACCHO is pleased to host a multi-part webinar series to help local health departments build capacity to engage in public health communication. Coordinated by NACCHO and the National Public Health Information Coalition (NPHIC)\, “Managing Media Relations” will help participants learn basic media relations principles; understand what NOT to say; understand how to change the conversation to YOUR message; and where to look for help when things go wrong. \nLearning Objectives \n\nIntroduce basic principles of interacting with and pitching local media\nUnderstand different types of media communications tactics\, (e.g.\, press releases\, backgrounders\, media advisories and press briefings)\nLearn best practices for educating media partners on health topics/data to avoid inaccuracy\n\nFeatured Speakers \n\nRichard Sheehe\, Senior Strategist\, The Merritt Group & Senior Research Fellow\, George Washington University\nKristina Wieghmink\, M.Ed.\, Communication Specialist/Public Information Officer\, Ottawa County Dept. of Public Health\n\nThe webinar will be recorded for on-demand viewing. REGISTER TO JOIN.
URL:https://globalbiodefense.com/event/managing-media-relations-during-a-public-health-emergency/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190715
DTEND;VALUE=DATE:20190719
DTSTAMP:20240118T180211Z
CREATED:20190213T192233Z
LAST-MODIFIED:20240118T180211Z
UID:23490-1563148800-1563494399@globalbiodefense.com
SUMMARY:Summer Workshop on Pandemics\, Bioterrorism\, and Global Health Security: From Anthrax to Zika
DESCRIPTION:Threats to global health security continue to evolve due to the changing nature of conflict\, advances in science and technology\, globalization\, and the growing threat posed by emerging infectious diseases and pandemics. Pandemics\, Bioterrorism and Global Health Security: From Anthrax to Zika is a three-day\, non-credit summer workshop designed to introduce participants to the challenges facing the world at the intersection of national security\, public health\, and the life sciences. The workshop faculty are internationally recognized experts from the government\, private sector\, and academia who have been extensively involved with research and policy-making on public health\, biodefense\, and national security issues. \nThe workshop is organized by the Biodefense Graduate Program at the Schar School of Policy and Government and will be held at the Schar School’s campus in Arlington\, Virginia on July 15-18\, 2019. \nPrivate and public organizations face a number of challenges in adapting to the changing global biosecurity landscape. The spectrum of biological threats is diverse\, including naturally occurring disease outbreaks such as SARS\, Zika\, and Ebola\, lapses in biosafety\, dual-use research of concern\, and the threat of bioterrorism. A severe disease outbreak\, whether natural or man-made\, can affect not just public health\, but also public safety and national security. Pandemics and bioterrorist attacks will confront government agencies and the private sector with the need to make high-impact decisions with limited information during a rapidly evolving situation. Further complicating this domain is the dual-use nature of biology: the knowledge\, skills\, and technology developed for legitimate scientific and commercial purposes can be misused by those with hostile intent. Research with dangerous pathogens and the development of advanced biotechnologies such as synthetic biology and genome editing poses a dilemma for policy-makers and researchers who seek to maximize the benefits of such research while minimizing the risks. Thus\, public health\, law enforcement and national security agencies\, the pharmaceutical and biotech industries\, and the academic life sciences community need to develop new types of expertise\, adopt new types of risk assessment and risk management strategies\, and learn to collaborate with each other. \nImplementing these new priorities will require substantial organizational learning and change. But large organizations have deeply embedded professional norms and organizational culture that make them resistant to change\, even during times of crisis. Each organization responds with its own routines\, and its own distinctive view of “the threat\,” which dilutes new initiatives\, encourages stovepiping\, and impedes effective collaboration. These organizational tendencies grow even more pronounced during times of declining budgets. Thus\, while the need for collaboration is great\, the potential for differing organizational styles to produce conflict is high. \nThe 1976 swine flu scare\, 2001 anthrax letter attacks\, SARS and avian influenza outbreaks\, 2009 H1N1 influenza pandemic\, 2014-2016 Ebola outbreak in West Africa\, and 2015-2017 Zika outbreak provide rich case studies of how government agencies and international organizations have struggled to address novel biological threats\, make high-impact decisions with limited information\, and work effectively with new partners. The lessons from these cases are broadly applicable to both public and private organizations seeking to address current and emerging biosecurity risks. \nFeatures\n\nSyllabus and reading materials\nSocial hour after first day of course\nLight breakfast\, coffee\, and lunch provided on all days\nCertificate of Attendance\n\nCourses Objectives\n\nIdentify the range of biological threats and assess the risks they pose to public health and national security\nDescribe impediments to organizational change and identify strategies for overcoming these obstacles.\nExamine lessons learned from the SARS and avian flu outbreaks\, the 2009 influenza pandemic\, and the 2014-2016 West Africa Ebola outbreak.\nExplore the dual-use dilemma and how to balance the benefits of advanced biotechnologies against the safety and security risks they can pose.\nInvestigate the growing importance of biotechnology to the national economy\, domestic and international risks to biotechnology innovation\, and legal\, policy\, and regulatory measures for safeguarding the bioeconomy.\nUnderstand the technical\, political\, regulatory\, and financial obstacles to developing new medical countermeasures for bioterrorist and pandemic threats.\n\nWho Should Attend\nProfessionals and academics\, both domestic and international\, in public health\, the life sciences\, the biotechnology and pharmaceutical industries\, international affairs\, law enforcement\, emergency management\, and national security who have responsibilities for preventing\, preparing for\, or responding to pandemics\, bioterrorism\, and other threats to global health security. \nPast participants have come from a range of government agencies\, private and non-profit organizations\, and universities and think tanks including: \n\nDepartment of Health and Human Services\nNational Institutes of Health\nFood and Drug Administration\nBiomedical Advanced Research and Development Authority\nCenters for Disease Control and Prevention\nFederal Emergency Management Agency\nDepartment of Defense\nDefense Threat Reduction Agency\nLawrence Livermore National Laboratory\nPacific Northwest National Laboratory\nOak Ridge National Laboratory\nSandia National Laboratories\nCenter for Biosecurity and Biopreparedness in Denmark\nBiosecurity Office of the Netherlands\nRwanda Ministry of Agriculture\nPhilippine National Police Force\nNational Center for Disease Control and Public Health in Georgia\nDefence Research and Development Canada\nCRDF Global\nBattelle Memorial Institute\nEmergent BioSolutions\nBooz Allen Hamilton\nBAE Systems\nEngility\nNoblis\nQuest Diagnostics\nSynthetic Genomics\nSanofi\nBiotechnology Innovation Organization\nMerrick & Company\nVirginia Tech\nKent State University\nUniversity of South Florida\nInstitute for Defense Analysis\nMITRE\nUC Berkeley\nNational Defense University\nUniversity of Sussex\nSAIS\nGeorgetown University\nANSER\n\nRegistration\nPlease note that we will only be accepting payment by credit card for this event. \nPrior to May 1\, the course fee is $1\,200. After May 1\, the course fee is $1\,400. Discounts are available for George Mason University faculty\, students\, and alum and for groups of three or more from the same organization. If you qualify for one of these discounts or have any questions regarding registration\, please email biodefense@gmu.edu. \n*Cancellation Policy: Refunds will be available if cancelled prior to the start to the start of the workshop (July 15\, 2019). \nLogistics \nThe summer workshop will be held on July 15-18\, 2019 on the Arlington campus of the Schar School of Policy and Government. The Schar School is located in Founder’s Hall at 3351 Fairfax Drive in Arlington\, VA. The school is conveniently located two blocks from the Virginia Square-GMU Metro station on the Orange Line. Garage parking is also available. \nList of Instructors\nDavid R. Franz\, DVM\, PhD\, served in the U.S. Army Medical Research and Materiel Command for 23 of 27 years on active duty and retired as colonel. He served as commander of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and as deputy commander of the Medical Research and Materiel Command. Prior to joining the Command\, he served as group veterinarian for the 10th Special Forces Group (Airborne). His current standing committee appointments include the Department of Health and Human Services National Science Advisory Board for Biosecurity (NSABB)\, the National Academy of Sciences Committee on International Security and Arms Control\, the National Research Council Board on Life Sciences\, and the Senior Technical Advisory Committee of the National Biodefense Countermeasures Analysis Center. Dr. Franz was the chief inspector on three United Nations Special Commission biological warfare inspection missions to Iraq and served as technical advisor on long-term monitoring. He also served as a member of the first two US-UK teams that visited Russia in support of the Trilateral Joint Statement on Biological Weapons and as a member of the Trilateral Experts’ Committee for biological weapons negotiations. Dr. Franz was technical editor for the Textbook of Military Medicine on Medical Aspects of Chemical and Biological Warfare released in 1997. He serves as a Senior Mentor to the Program for Emerging Leaders at the National Defense University. He also serves on the Board of Integrated Nano-Technologies\, LLC. Dr. Franz holds an adjunct appointment as Professor for the department of Diagnostic Medicine and Pathobiology at the College of Veterinary Medicine\, Kansas State University. The current focus of his activities relates to the role of international engagement in the life sciences as a component of national security policy. Dr. Franz holds a DVM from Kansas State University and a PhD in physiology from Baylor College of Medicine. \nGregory D. Koblentz\, PhD\, MPP\, is an Associate Professor in the Schar School of Policy and Government and Director of the Biodefense Graduate Program at George Mason University. During 2012-2013\, he was a Stanton Nuclear Security Fellow at the Council on Foreign Relations. Dr. Koblentz is also a member of the Scientist Working Group on Chemical and Biological Weapons at the Center for Arms Control and Non-Proliferation in Washington. He previously worked at Georgetown University\, the Executive Session for Domestic Preparedness at Harvard University\, and the Carnegie Endowment for International Peace. He is the author of Strategic Stability in the Second Nuclear Age (Council on Foreign Relations\, 2014)\, Living Weapons: Biological Warfare and International Security (Cornell University Press\, 2009) and co-author of Tracking Nuclear Proliferation (Carnegie Endowment for International Peace\, 1998). He serves on the editorial boards of Nonproliferation Review\, World Medical and Health Policy\, and Global Health Governance. His teaching and research interests focus on international security\, weapons of mass destruction\, terrorism\, and homeland security. He received his PhD from the Massachusetts Institute of Technology\, his Master in Public Policy from the John F. Kennedy School of Government\, and his BA from Brown University. For more information\, see https://schar.gmu.edu/about/faculty-directory/gregory-koblentz \nJens H. Kuhn\, MD\, PhD\, PhD\, MS\, is a Research Leader at Battelle Memorial Institute\, Columbus\, OH\, USA\, tasked as the Virology Lead (Contractor) at NIH/NIAID/DCR’s Biosafety Level 4 facility\, the Integrated Research Facility at Fort Detrick (IRF-Frederick) in Frederick\, MD\, USA. Dr. Kuhn specializes in highly virulent viral human and animal pathogens. He is the author of “Filoviruses: A Compendium of 40 Years of Epidemiological\, Clinical\, and Laboratory Studies” (Vienna: Springer\, 2008) and co-author of “The Soviet Biological Weapons Program—A History” (Cambridge: Harvard University Press\, 2012)\, and has studied and worked in Germany\, Italy\, Malta\, Russia\, South Africa\, and South Korea. In the US\, he rotated through or worked at Harvard Medical School\, Boston\, MA; the Arthropod-borne Infectious Disease Laboratory (AIDL) in Fort Collins\, CO; the Centers for Disease Control and Prevention (CDC) in Atlanta\, GA; and the US Army Medical Research Institute of Infectious Diseases (USAMRIID) in Frederick\, MD. Dr. Kuhn was the first western scientist with permission to work in a former Soviet biological warfare facility\, SRCVB “Vektor” in Siberia\, Russia\, within the US Department of Defense’s Cooperative Threat Reduction (CTR) Program. Dr. Kuhn was a contributor to the Center for International and Security Studies at Maryland’s Controlling Dangerous Pathogens Project and a member of the Center for Arms Control and Nonproliferation’s CBW Scientist Working Group. He is currently a Subcommittee Chair and Member of the Executive Committee of the International Committee on Taxonomy of Viruses (ICTV)\, Chair of the ICTV Bunyavirales and Filoviridae Study Groups\, and a member of the ICTV Arenaviridae\, Bornaviridae\, Nairoviridae\, and Nyamiviridae Study Groups. He furthermore serves as a Subject Matter Expert for NCBI for all mononegaviruses as a member of the NCBI Genome Annotation Virus Working Group and the database RefSeq. Dr. Kuhn is a member of the editorial boards of 10 journals\, and has been a peer reviewer for more than 60 journals\, including Cell\, Cell Host & Microbe\, Emerging Infectious Diseases\, JAMA\, The Lancet. Infectious Diseases\, Nature\, Nature Microbiology\, Nature Protocols\, PLoS Pathogens\, Science\, and Journal of Virology. Dr. Kuhn also was a member of the 2009-2011 US National Academy of Sciences’ Committee on “Animal Models for Assessing Countermeasures to Bioterrorism Agents”; and was part of several AAAS and US State Department bioengagement efforts in the BMENA Region\, Turkey\, and the NIS countries. Dr. Kuhn can be found on LinkedIn at http://www.linkedin.com/pub/jens-h-kuhn/1b/817/72 and on ResearchGate at https://www.researchgate.net/profile/Jens_Kuhn. \nSanford L. Weiner is a Research Associate in the Center for International Studies at the Massachusetts Institute of Technology\, and a Visiting Fellow at Imperial College\, University of London. For several decades he has done international comparative policy studies of public health agencies\, and research on national security policies and environmental policies. He has published on policymaking at the Centers for Disease Control\, the phase-out of CFCs\, toxic substance control\, and innovation in the Air Force. He is currently studying responses to pandemic flu in Europe and the United States\, and the politics of alternative energy projects. He directs a Professional Education summer course at MIT on “Technology\, Innovation and Organizations.” He has also taught in professional education courses for the Royal Society Technology Fellows (London)\, the National University of Singapore\, UC San Diego\, and in Stockholm. Before MIT he was on the research staffs of the School of Public Policy at UC Berkeley\, the Health Policy Center at Brandeis\, and the Harvard School of Public Health. \nEdward You is a Supervisory Special Agent in the FBI’s Weapons of Mass Destruction Directorate\, Biological Countermeasures Unit. Mr. You is responsible for creating programs and activities to coordinate and improve FBI and interagency efforts to identify\, assess\, and respond to biological threats or incidents. These efforts include expanding FBI outreach to the Life Sciences community to address biosecurity. Before being promoted to the Weapons of Mass Destruction Directorate\, Mr. You was a member of the FBI Los Angeles Field Office Joint Terrorism Task Force and served on the FBI Hazardous Evidence Response Team. \nMr. You has also been directly involved in policy-making efforts with a focus on biosecurity. He is an active Working Group member of the National Security Council Interagency Policy Committee on Countering Biological Threats and an Ex Officio member of the NIH National Science Advisory Board for Biosecurity. He also serves on two committees for the National Academies of Sciences\, the Institute of Medicine’s Forum on Microbial Threats and the Committee on Science\, Technology\, and Law’s Forum on Synthetic Biology. \nPrior to joining the FBI\, Mr. You worked for six years in graduate research focusing on retrovirology and human gene therapy at the University of Southern California\, Keck School of Medicine. He subsequently worked for three years at the biotechnology firm AMGEN Inc. in cancer research. \nAndrew Kilianski is currently a GMU professor and biological scientists at the DoD. His work focuses on combating current and future threats from weapons of mass destruction in addition to teaching classes on biosurveillance and virology in the GMU Biodefense graduate program. Dr. Kilianski was previously a National Research Council fellow with the US Army at Edgewood Chemical Biological Center. During his tenure at ECBC\, his research focused on biosurveillance and the identification and characterization of novel agents that threaten today’s warfighter.  Dr. Kilianski’s research interests also included emerging viral pathogens and public health and biodefense policy\, and he was selected as an Emerging Leaders in Biosecurity Initiative Fellow for 2015.  His research has been published in peer-reviewed journals such as PLoS Pathogens\, Journal of Virology\, and Emerging Infectious Diseases while also publishing multiple commentary and op-ed articles.  He received his Ph.D. in Microbiology and Immunology from Loyola University Chicago where his dissertation research involved uncoupling virus-host interactions important for coronavirus pathogenesis and developing antiviral compounds against emerging coronaviruses (SARS-CoV and MERS-CoV). During the workshop\, Dr. Kilianski will be lecturing on biosurveillance and its role as an integral component of any biodefense strategy and how U.S. policy has mandated that such efforts be accelerated. He notes that “. This construct\, and how the US and international entities engage in biosurveillance will be covered\, as well as how recent Ebola and Zika virus outbreaks have tested the system. Emerging technologies and their role in biosurveillance will also be reviewed. Finally\, paths toward integrated biosurveillance for the US and international communities will presented for group discussion discussion.” \nJamechia Hoyle\, DHSc\, MPH\, MS\, PMP is the 2017-2018 Coordinator of the Next Generation Global Health Security Leaders. Dr. Hoyle is a Public Health Consultant and Adjunct Professor at George Mason University\, Fairfax\, VA.  She also instructs preparedness course at the National Center for Biomedical Research and Training\, Baton Rouge\, LA.  Dr. Hoyle has managed multiple public health program activities related to emergency preparedness and response\, operational capacity\, strategic thinking\, response strategies\, and clinical guidance for various Category A\, B\, and C bioterrorism agents.  In addition\, Dr. Hoyle has a strong background in international health\, with a primary focus on project management\, program evaluation\, HIV/AIDS\, sanitation and hygiene and clean water.  Her work has taken her to Liberia\, South Africa\, India\, Haiti\, and Sri Lanka. \nKendall Hoyt is an Assistant Professor at the Geisel School of Medicine at Dartmouth where she studies U.S. biodefense policy\, global health policy\, and biomedical R&D strategy. She is also a lecturer at the Thayer School of Engineering at Dartmouth College where she teaches courses on technology and biosecurity. She is the author of Long Shot: Vaccines for National Defense\, Harvard University Press\, 2012. She currently serves as an advisor to the Coalition for Epidemic Preparedness Innovations (CEPI). CEPI develops vaccines for diseases that have epidemic potential\, such as Lassa\, Nipah\, and MERS. \nKendall Hoyt received her Ph.D. in the History and Social Study of Science and Technology at the Massachusetts Institute of Technology in 2002 and was a Fellow in the International Security Program at the Belfer Center for Science and International Affairs at the Harvard Kennedy School of Government from 2002-2004. Prior to obtaining her degree\, she worked in the International Security and International Affairs division of the White House Office of Science and Technology Policy\, the Washington DC office of McKinsey and Company\, and the Center for the Management of Innovation and Technology at the National University of Singapore. \nFor more biodefense news\, visit the Pandora Report \nPlease contact biodefense@gmu.edu  if you have any additional questions.
URL:https://globalbiodefense.com/event/summer-workshop-on-pandemics-bioterrorism-and-global-health-security-from-anthrax-to-zika/
LOCATION:George Mason University\, Arlington Campus\, Founders Hall\, 3351 Fairfax Drive\, Arlington\, VA\, 22201\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/02/1ff229a13a5c3bcac76d547c7704b0a8.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190630
DTEND;VALUE=DATE:20190701
DTSTAMP:20190619T043333Z
CREATED:20190602T043051Z
LAST-MODIFIED:20190619T043333Z
UID:29329-1561852800-1561939199@globalbiodefense.com
SUMMARY:Estimated Release Date of Draft WHO Roadmap on Neglected Tropical Diseases 2012–2020
DESCRIPTION:At its eleventh meeting in 2018\, the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) recommended that WHO initiate a consultative process with the global NTD community to set new targets and milestones beyond 2020 to achieve the health-related 2030 United Nations Sustainable Development Goals (SDGs). \nPhase 1 feedback was collected\, summarized and presented on 29-30 April 2019 at a STAG-NTD meeting. A second round of feedback from stakeholders will take place following the late June release of the Roadmap draft with the goal of finalizing the Roadmap and milestones by 1 August. \nSource: World Health Organization
URL:https://globalbiodefense.com/event/estimated-release-date-of-draft-who-roadmap-on-neglected-tropical-diseases-2012-2020/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
END:VCALENDAR